Chai Discovery nabs $400M Series C as AI-designed antibodies reach Big Pharma - SiliconANGLE

Chai Discovery raises $400M as AI drug discovery booms

Chai Discovery's $400M Series C triples its value to $3.8bn, a fresh sign that AI drug discovery has moved from promise to deployment at big pharma.